Medications

Researchers examine cancer drug guidelines and FDA approvals

Drugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments. Under the expedited review pathway ...

Oncology & Cancer

The current state of immunotherapy in colorectal cancer

Colorectal cancer (CRC) is a major health concern worldwide, characterized by high incidence and mortality rates. Despite advances in treatment, metastatic CRC (mCRC) remains particularly challenging.

page 2 from 40